论文信息 - Antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients (pts) with advanced HER2+ (IHC3+) gastric carcinoma (GC). - 字舞流文

Antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients (pts) with advanced HER2+ (IHC3+) gastric carcinoma (GC).

J. Lacy | S. Park | Y. Bang | P. Moore | Yoon-Koo Kang | P. Enzinger | Keun-Wook Lee | K. Lim | J. Odegaard | J. Yen | D. Catenacci | J. Davidson-Moncada | H. Uronis | P. Gold | J. Baughman | Francine Z Chen | M. Ng | A. Franovic | A. Wynter-Horton | Tony Wu